Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2026-01-31 @ 11:46 AM
Study NCT ID:
NCT00269750
Status:
COMPLETED
Last Update Posted:
2011-05-19
First Post:
2005-12-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.
Sponsor:
Alza Corporation, DE, USA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR005968
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None